Part I: General Information Date Prepared: March 2015 Name: Shuji Ogino Office Address

Download 0.66 Mb.
Date conversion08.07.2018
Size0.66 Mb.
1   2   3   4   5   6   7

Other Peer-Reviewed Publications:

1. Ogino S, Ro JY, Redline RW. Malignant rhabdoid tumor. A phenotype? An entity? – A controversy revisited [review]. Adv Anat Pathol 2000;7:181-190.

2. Ogino S, Wilson RB. Genetic testing and risk assessment for spinal muscular atrophy (SMA) [review]. Hum Genet 2002;111:477-500.
3. Ogino S, Wilson RB. Spinal muscular atrophy: molecular genetics and diagnostics [review]. Expert Rev Mol Diagn 2004;4:15-29.
4. Ogino S, Wilson RB. Bayesian analysis and risk assessment in genetic testing and counseling [review]. J Mol Diagn 2004:6:1-9.
5. Giovannucci E, Ogino S. DNA methylation, field effects, and colorectal cancer [editorial].

J Natl Cancer Inst 2005;97:1317-1319.
6. Ogino S, Goel A. Molecular classification and correlates in colorectal cancer [review].

J Mol Diagn 2008;10:13-27.
7. Monzon FA, Ogino S, Hammond ME, Halling KC, Bloom K, Nikiforova MN. The role of KRAS mutation testing in the management of patients with metastatic colorectal cancer [review].

Arch Pathol Lab Med 2009;133:1600-1606.
8. The Methylation Working Group of the Association for Molecular Pathology (AMP) Clinical Practice Committee (Contributing members of the AMP Methylation Working Group: Sepulveda AR, Jones D, Ogino S, Samowitz W, Gulley ML, Edwards R, Levenson V, Pratt VM, Yang B, Nafa K, Yan L, Vitazka P). CpG Methylation Analysis - Current Status of Clinical Assays and Potential Applications in Molecular Diagnostics: A Report of the Association for Molecular Pathology [review].

J Mol Diagn 2009;11:266-278.
9. Ogino S, Stampfer M. Lifestyle factors and microsatellite instability in colorectal cancer: the evolving field of molecular pathological epidemiology [editorial]. J Natl Cancer Inst 2010;102:365-367.
10. Muralidharan K, Wilson RB, Ogino S, Nagan N, Curtis C, Schrijver I. AMP Position Statement on population carrier screening for Spinal Muscular Atrophy [special article]. J Mol Diagn 2011;13:3-6.
11. Ogino S, Chan AT, Fuchs CS, Giovannucci E. Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field [review]. Gut 2011;60:397-411.
12. Ogino S, Galon J, Fuchs CS, Dranoff G. Cancer immunology – integrated analysis of host and tumor factors for personalized medicine [review]. Nat Rev Clin Oncol 2011:8:711-719.

13. Funkhouser WK, Lubin IM, Monzon FA, Zehnbauer BA, Evans JP, Ogino S, Nowak JA. Relevance, pathogenesis, and testing algorithm for mismatch repair-defective colorectal carcinomas: A report of the Association for Molecular Pathology. J Mol Diagn 2012;14:91-103.
14. Yamauchi M, Lochhead P, Morikawa T, Huttenhower C, Chan AT, Giovannucci E, Fuchs CS, Ogino S. Colorectal cancer: a tale of two sides or a continuum? [review - leading article]

Gut 2012;61:794-797.
15. Ogino S, King EE, Beck AH, Sherman ME, Milner DA, Giovannucci E. Interdisciplinary education to integrate pathology and epidemiology: Towards molecular and population-level health science [special article]. Am J Epidemiol 2012;176:659-667.
16. Ogino S, Giovannucci E. Lifestyle factors and colorectal cancer microsatellite instability - Molecular pathological epidemiology science, based on unique tumour principle [invited commentary]. Int J Epidemiol 2012;41:1072-1074.
17. Ogino S, Beck AH, King EE, Sherman ME, Milner DA, Giovannucci E. Ogino et al. respond to “The 21st century epidemiologist” [reply to invited commentary]. Am J Epidemiol 2012;176:672-674.
18. Ogino S, Fuchs CS, Giovannucci E. How many molecular subtypes? Implications of the unique tumor principle in personalized medicine [review]. Expert Rev Mol Diagn 2012;12:621-628.
19. Rex DK, Ahnen DJ, Baron JA, Batts KP, Burke CA, Burt RW, Goldblum JR, Guillem JG, Kahi CJ, Kalady MF, O'Brien MJ, Odze RD, Ogino S, Parry S, Snover DC, Torlakovic EE, Wise PE, Young J, Church J. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol 2012;107:1315-1329.
20. Galon J, Franck P, Marincola FM, Angell HK, Thurin M, Lugli A, Zlobec I, Berger A, Bifulco C, Botti G, Tatangelo F, Britten CM, Kreiter S, Chouchane L, Delrio P, Hartmann A, Asslaber M, Maio M, Masucci GV, Mihm M, Vidal-Vanaclocha F, Allison JP, Gnjatic S, Hakansson L, Huber C, Singh-Jasuja H, Ottensmeier C, Zwierzina H, Laghi L, Grizzi F, Ohashi PS, Shaw PA, Clarke BA, Wouters BG, Kawakami Y, Hazama S, Okuno K, Wang E, O'Donnell-Tormey J, Lagorce C, Pawelec G, Nishimura MI, Hawkins R, Lapointe R, Lundqvist A, Khleif SN, Ogino S, Gibbs P, Waring P, Sato N, Torigoe T, Itoh K, Patel PS, Shukla SN, Palmqvist R, Nagtegaal ID, Wang Y, D'Arrigo C, Kopetz S, Sinicrope FA, Trinchieri G, Gajewski TF, Ascierto PA, Fox BA. Cancer classification using the Immunoscore: a worldwide task force [review]. J Transl Med 2012;10:205.
21. Ogino S, Lochhead P, Chan AT, Nishihara R, Cho E, Wolpin BM, Meyerhardt AJ, Meissner A, Schernhammer ES, Fuchs CS, Giovannucci E. Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease [review].

Mod Pathol 2013;26:465-484.
22. Fuchs CS, Ogino S. Aspirin therapy for colorectal cancer with PIK3CA mutation: simply complex! [“Understanding The Pathway” article] J Clin Oncol 2013;31:4358-4361.
23. Kuller LH, Bracken MB, Ogino S, Prentice RL, Tracy RP. The role of epidemiology in the era of molecular epidemiology and genomics: Summary of the 2013 AJE-sponsored Society of Epidemiologic Research Symposium. Am J Epidemiol 2013;178:1350-1354.

24. Field AE, Camargo Jr CA, Ogino S. The merits of subtyping obesity: one size does not fit all [viewpoint]. JAMA 2013;310:2147-2148.
25. Sukawa Y, Ogino S. Molecular pathological Epidemiology (MPE) approach to cancer epigenomics. Experimental Med 2014;32. (Japanese)
26. Galon J, Mlecnik B, Bindea G, Angell HK, Berger A, Lagorce C, Lugli A, Zlobec I, Hartmann A, Bifulco C, Nagtegaal ID, Palmqvist R, Masucci GV, Botti G, Tatangelo F, Delrio P, Maio M, Laghi L, Grizzi F, Asslaber M, D'Arrigo C, Vidal-Vanaclocha F, Zavadova E, Chouchane L, Ohashi PS, Shaw PA, Clarke BA, Wouters BG, Kawakami Y, Hazama S, Okuno K, Ogino S, Gibbs P, Waring P, Sato N, Torigoe T, Itoh K, Patel PS, Shukla SN, Wang Y, Kopetz S, Sinicrope FA, Ascierto PA, Marincola FM, Fox BA, Pagès F. Towards the introduction of the Immunoscore in the classification of malignant tumors [review]. J Pathol 2014;232:199-209.
27. Ogino S, Lochhead P, Giovannucci E, Meyerhardt JA, Fuchs CS, Chan AT. Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology [review]. Oncogene 2014;33:2949-2955.
28. Li T, Ogino S, Qian ZR. Toll-like receptor signaling in colorectal cancer: Carcinogenesis to cancer therapy. World J Gastroenterol 2014;20;17699-17708.

29. Lochhead P, Chan AT, Giovannucci E, Fuchs CS, Wu K, Nishihara R, O’Brien M, Ogino S. Progress and opportunities in molecular pathological epidemiology of colorectal premalignant lesions [review]. Am J Gastroenterol 2014;109:1205-1214.
30. Epplein M, Bostick RM, Mu L, Ogino S, Braithwaite D, Kanetsky PA. Challenges and opportunities in international molecular cancer prevention research: A report from the ASPO Molecular Epidemiology and the Environment and International Issues in Cancer Interest Group [meeting report]. Cancer Epidemiol Biomarkers Prev 2014;23:2613-2617.
31. Lochhead P, Chan AT, Nishihara R, Fuchs CS, Beck AH, Giovannucci E, Ogino S. Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression [review]. Mod Pathol 2015: in press (published online).
32. Nishi A, Kawachi I, Koenen KC, Wu K, Nishihara R, Ogino S. Lifecourse epidemiology and molecular pathological epidemiology [review]. Am J Prev Med 2015;48:116-119.

Practice Guidelines and Standards:

1. Rainen L, Arbique JC, Asthana D, Earley MC, Geiszler RL, Krieg-Schneider F, Mannhalter C, Ogino S, Parish GT, Ballas C, Chandler LJ, Fernandes H, Ferrari M, Lechpammer M, WalkerPeach CR, Williams LO. Clinical and Laboratory Standards Institute (CLSI) Document MM13-A (Vol 25. Number 31). Collection, transport, preparation and storage of specimens for molecular methods; approved guideline. Clincal and Laboratory Standards Institute, Wayne, PA 2005.

2. Ogino S, Gulley ML, den Dunnen JT, Wilson RB, Association for Molecular Pathology Training and Education Committee. Standard mutation nomenclature in molecular diagnostics: practical and educational challenges. J Mol Diagn 2007;9:1-6.
3. Gulley ML, Braziel RM, Halling KC, Hsi ED, Kant JA, Nikiforova MN, Nowak JA, Ogino S, Oliveira A, Polesky HF, Silverman L, Tubbs RR, Van Deerlin VM, Vance GH, Versalovic J, for the Molecular Pathology Resource Committee, College of American Pathologists. Clinical laboratory reports in molecular pathology. Arch Pathol Lab Med 2007;131:852-863.
4. Febbo PG, Ladanyi M, Aldape KD, De Marzo AM, Hammond ME, Hayes DF, Iafrate AJ, Kelley RK, Marcucci G, Ogino S, Pao W, Sgroi DC, Birkeland ML. NCCN Task Force Report: Evaluating the Clinical Utility of Tumor Markers in Oncology. J Natl Compr Canc Netw 2011;9:S-1-S-32.

Non-Peer Reviewed Publications:
1. Ogino S. Spinal muscular atrophy [chapter]. In Encyclopedia of Diagnostic Genomics and Proteomics, edited by Fuchs J and Podda M. Dekker Publication, New York, NY. 2005.
2. Ogino S. Spinal muscular atrophy [chapter]. In Encyclopedic Reference of Genomics and Proteomics in Molecular Medicine, edited by Ganten D and Ruckpaul K. Springer-Verlag, Heidelberg, Germany. 2006.
3. Ogino S, Wilson RB. Bayesian analysis [chapter]. In Molecular Pathology in Clinical Practice, edited by Leonard DG. Springer. 2007.
4. Hazra A, Ogino S. Epigenomic diversity of colorectal cancer [chapter]. In Epigenomics, edited by Appasani K. Cambridge University Press 2012.
5. Wilson RB, Ogino S. Bayesian analysis [chapter]. In Molecular Pathology in Clinical Practice, 2nd edition, edited by Leonard DG. Springer. 2012.
6. Idowu MO, Ogino S. Standard nomenclature: why bother? [chapter]. In Molecular Oncology Testing For Solid Tumors: A Pragmatic Approach, edited by Idowu MO, Dumur CI, and Garrett CT. Springer. 2015 (in press).


1. Ogino S. A method to compensate for different amplification efficiencies. J Mol Diagn 2001;3:189-190.

  1. Ogino S, Van Deerlin VMD, Wilson RB. Comment on SMN2-deletion in childhood-onset spinal muscular atrophy. Am J Med Genet 2002;109:243-244.

3. Ogino S, Wilson RB. SMN dosage analysis and risk assessment for spinal muscular atrophy. Am J Hum Genet 2002;70:1596-1598.

4. Ogino S, Wilson RB. The practice of science at its best. Fertil Steril 2003;80:228-229.
5. Ogino S, Wilson RB. Importance of the use of standard nomenclature for SMN1 small intragenic (“subtle”) mutations. Hum Mut 2004;23:392-393.
6. Chan AT, Ogino S, Fuchs CS. Aspirin, COX-2, and the risk of colorectal cancer: The authors’ reply. New Engl J Med 2007;357:824-825.
7. Samowitz WS, Ogino S. DNA methylation in breast and colorectal cancers. Mod Pathol 2008;21:1054.
8. Wilson RB, Ogino S. Carrier frequency of spinal muscular atrophy. Lancet 2008;372:1542.
9. Chan AT, Ogino S, Fuchs CS. Aspirin use, colorectal cancer survival, and loss to follow-up: The authors’ reply. JAMA 2009;302:2549-2550.
10. Ogino S, Meyerhardt JA, Fuchs CS. Reply to Watanabe et al. J Clin Oncol 2010;28:e120.
11. Nosho K, Ogino S. Reply to letter entitled ‘How dense, how intense? Role of tumour-infiltrating lymphocytes across colorectal cancer stages’. Re: Nosho et al. Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review. J Pathol 2010; 222: 350-366. J Pathol 2011;225: 629-630.
12. Søreide K, Ogino S. Microsatellite instability and retrieval of lymph nodes in stage III colon cancer: harbinger or hermit? Hum Pathol 2012;43:1785-1786.
13. Ogino S, Liao X, Chan AT. Aspirin, PIK3CA mutation, and colorectal-cancer survival. N Engl J Med 2013;368:289-290.

1   2   3   4   5   6   7

The database is protected by copyright © 2016
send message

    Main page